Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04091750 |
Title | Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma |
Recruitment | Suspended |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Georgetown University |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Lombardi Comprehensive Cancer Center | Washington | District of Columbia | 20007 | United States | Details | |
Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute | Baltimore | Maryland | 21237 | United States | Details | |
John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details |